您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Cemiplimab
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cemiplimab
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CAS NO:1801342-60-8
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
Cemiplimab (Anti-Human PD-1) 是一种具有高亲和力的程序性死亡受体-1 (PD-1) 单克隆 IgG4 抗体,可阻断 PD-1/PD-L1 介导的 T 细胞抑制。常用于鳞状细胞皮肤癌研究。
生物活性

Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonalIgG4antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skincancerresearch[1][2].

体内研究
(In Vivo)

Cemiplimab (i.p., 10 mg/kg, five injections within 2 weeks) can increased the proportion of effector T cells in tumors and dLNs to reduce tumor growth by combined immunotherapy with REGN3767 in MC38.Ova tumor mice model[2].

Animal Model:Female human PD-1×LAG-3 knockin mice (8-10 weeks) with MC38.Ova cells[2]
Dosage:10 mg/kg
Administration:Intraperitoneal injection; five injections within 2 weeks
Result:Partially inhibited the growth of MC38.Ova tumors and prolonged the survival of mice by administering alone.
Significantly increased the proportion of CD4+TILs in IFNγ and TNFα by combined immunotherapy with REGN3767.
Clinical Trial
CAS 号

1801342-60-8

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.